Unique Wealth Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$610K Buy
+10,582
New +$608K 0.22% 131
2025
Q4
Sell
-27,020
Closed -$1.22M 220
2025
Q3
$1.22M Buy
27,020
+14,824
+122% +$692K 0.47% 49
2025
Q2
$565K Buy
+12,196
New +$599K 0.23% 133
2024
Q4
Sell
-5,741
Closed -$297K 196
2024
Q3
$297K Buy
5,741
+5,571
+3,277% +$261K 0.13% 179
2024
Q2
$9.22K Buy
+170
New +$7.61K ﹤0.01% 323

Other funds holding BMY

Unique Wealth Strategies's BMY Position: Q2 2026 in Review

Unique Wealth Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 10,582 shares worth $610K. The stake represents 0.22% of the portfolio and ranks #131 among its holdings. This is a return to the name: Unique Wealth Strategies previously reported a position in BMY as recently as Q3 2025.

Unique Wealth Strategies first reported a position in BMY in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.22M in Q3 2025. 464 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Unique Wealth Strategies held 10,582 shares of Bristol-Myers Squibb worth $610K as of Q2 2026.
  • Bristol-Myers Squibb was a new Unique Wealth Strategies position in Q2 2026.
  • Bristol-Myers Squibb made up 0.22% of Unique Wealth Strategies's portfolio in Q2 2026, its #131 holding.
  • Unique Wealth Strategies first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 5 quarters since.
  • Unique Wealth Strategies's Bristol-Myers Squibb position peaked at $1.22M in Q3 2025.
  • 464 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.